Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Adult Vaccines Market?

The market size for adult vaccines has seen significant growth in recent years. Its size is predicted to increase from $22.82 billion in 2024 to $24.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. This historic growth can be credited to factors such as the rise in the elderly population, government-initiated vaccination programs, an increase in awareness about preventative healthcare, advancements in vaccine development and innovation, as well as public health campaigns.

What Growth Rate Is Forecasted for the Adult Vaccines Market by 2029?

In the coming years, the adult vaccines market size is anticipated to experience notable expansion. The projection suggests a growth to $35.22 billion in 2029, backed by a compound annual growth rate (CAGR) of 9.5%. The anticipated growth during this period is attributed to factors such as the emergence of new infectious issues, the intensification of focus on immunization registries, the escalating threat of antimicrobial resistance, global initiatives for pandemic readiness, a shift towards personalized vaccines, and increased emphasis on maternal immunization. The future trends within this frame include the integration of digital health, innovations in vaccine production technology, partnerships between government entities and pharmaceutical companies, advancements in vaccine delivery mechanisms, and broadening immunization programs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

Which Key Companies Are Shaping the Future of the Adult Vaccines Market?

Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Which Factors Are Driving Demand in the Adult Vaccines Industry?

The surge in cases of infectious diseases is propelling the growth of the adult vaccine market. Transmissible infections, which are easily spread among individuals, can be effectively combatted with vaccines that enable the body to build resistance against them. For example, the US Centers for Disease Control and Prevention reported in March 2023 that the number of tuberculosis cases in 2022 was 8,300, a rise from 7,874 cases in 2021. The incidence of TB also saw a minor increase, from 2.4 to 2.5 per 100,000 people in 2022. As a result, the escalating frequency of infectious diseases is fueling the expansion of the adult vaccine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

How Is the Adult Vaccines Market Segmented by Several Divisions?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

What are the Emerging Market Trends Driving the Growth of the Adult Vaccines Industry?

The emergence of product innovations is a significant trend making waves in the adult vaccines market. Leading market players are rolling out inventive products to maintain their market standing. For example, in August 2022, the UK’s biopharma company, GSK, and IQVIA, an advanced analytics, technology solutions, and clinical research services provider from India, unveiled Vaccine Track, a trend-data platform intended to boost adult immunization across communities countrywide. This tool will deliver regular and pertinent data on trends to pay attention to and amplify public health initiatives.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Regions Are Driving Growth in the Adult Vaccines Market?

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9038

This Report Delivers Insight On:

1. How big is the adult vaccines market, and how is it changing globally?

2. Who are the major companies in the adult vaccines market, and how are they performing?

3. What are the key opportunities and risks in the adult vaccines market right now?

4. Which products or customer segments are growing the most in the adult vaccines market?

5. What factors are helping or slowing down the growth of the adult vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model